SUCCESSFUL RETREATMENT OF ALLOGRAFT REJECTION WITH OKT3
- 1 January 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 47 (1) , 88-91
- https://doi.org/10.1097/00007890-198901000-00020
Abstract
An abstract is unavailable. This article is available as a PDF only.This publication has 5 references indexed in Scilit:
- PROPHYLACTIC USE OF OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY RECIPIENTS UTILIZATION OF OKT3 AS THE SOLE IMMUNOSUPPRESSIVE AGENTTransplantation, 1986
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal AllograftsNew England Journal of Medicine, 1981
- Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?Proceedings of the National Academy of Sciences, 1981
- INVIVO EFFECTS OF MURINE HYBRIDOMA MONOCLONAL-ANTIBODY IN A PATIENT WITH T-CELL LEUKEMIA1981